Jennifer Hunn
Family Health · Saint Peters, MONPI 1497101133
Payments from drug & device makers
Across 354 payments — averaging $15.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$746
- Lilly USA, LLC$479
- Amgen$420
- Teva Pharmaceuticals USA, Inc.$400
- Pfizer$239
- plus $2K from 33 others
What the payments were for
- Food & beverage$5,26498%
- Education$1112%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 79 | $1,011 |
| Novo Nordisk | 51 | $746 |
| Lilly USA, LLC | 26 | $479 |
| Amgen | 24 | $420 |
| Teva Pharmaceuticals USA, Inc. | 18 | $400 |
| Pfizer | 29 | $239 |
| Biohaven Pharmaceutical Holding Company Ltd. | 29 | $221 |
| Otsuka America Pharmaceutical, Inc. | 12 | $215 |
| AstraZeneca | 11 | $198 |
| UCB, Inc. | 5 | $171 |
| Novartis | 9 | $154 |
| Boehringer Ingelheim | 7 | $139 |
| Lundbeck LLC | 5 | $102 |
| Mylan Specialty L.p. | 6 | $101 |
| Viatris Specialty LLC | 4 | $79 |
| GSK | 2 | $76 |
| Sanofi-aventis U.S. LLC | 3 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $51 |
| Johnson & Johnson | 4 | $51 |
| Exact Sciences | 3 | $49 |
| Bayer | 3 | $45 |
| Abiomed | 1 | $40 |
| Vanda Pharmaceuticals Inc. | 1 | $35 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $34 |
| Sunovion Pharmaceuticals Inc. | 2 | $32 |
| Dexcom, Inc. | 1 | $32 |
| Amarin Pharma, Inc. | 2 | $25 |
| Astellas Pharma US Inc | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Ironshore Pharmaceuticals Inc. | 1 | $16 |
| Neurocrine Biosciences, Inc. | 1 | $16 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
| Merck | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Impel Pharmaceuticals Inc. | 1 | $13 |
| Adlon Therapeutics L.p. | 1 | $13 |
| Eisai Inc. | 1 | $13 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| Currax Pharmaceuticals LLC | 1 | $12 |
How this compares
Too few family health providers in Missourito place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 71 | $80,403 |
| EliquisApixaban | 40 | $43,194 |
| MounjaroTirzepatide | 40 | $42,020 |
| Tresiba Flextouch U-100Insulin Degludec | 58 | $40,160 |
| MyrbetriqMirabegron | 39 | $25,299 |
| FarxigaDapagliflozin Propanediol | 23 | $22,222 |
| Spiriva RespimatTiotropium Bromide | 33 | $21,817 |
| VraylarCariprazine Hcl | 13 | $21,341 |
| LinzessLinaclotide | 31 | $19,891 |
| XareltoRivaroxaban | 35 | $19,755 |
| Tresiba Flextouch U-200Insulin Degludec | 23 | $17,506 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 12 | $16,226 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 12 | $10,703 |
| Arnuity ElliptaFluticasone Furoate | 29 | $9,364 |
| JardianceEmpagliflozin | 13 | $9,136 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $746 | $80,40371 claims |
| PfizerEliquis, Protonix | $239 | $48,29452 claims |
| Lilly USA, LLCMounjaro | $479 | $42,02040 claims |
| AbbVieVraylar, Linzess | $1,011 | $41,23244 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $198 | $40,90061 claims |
| Boehringer IngelheimSpiriva Respimat, Jardiance, Stiolto Respimat | $139 | $39,48560 claims |
| Astellas Pharma US IncMyrbetriq | $18 | $25,29939 claims |
| Johnson & JohnsonXarelto | $51 | $19,75535 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $56 | $16,22612 claims |
| GSKArnuity Ellipta | $76 | $9,36429 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few family health providers in Missourion file to place this against a meaningful peer group, so we don't.
Other family health in Saint Peters
- Andrew GarnerCape Girardeau$7K
- Jessica BellCuba$6K
- Heather CheaneyFarmington$4K
- Susan VogelsmeierMarshall$293
- Bernita BellCape Girardeau$190
- Jana GraberKansas City$27
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.